SPEAKER: Christian Capitini, MD

Title: Genetically Modified Immune Effector Cells as Personalized Medicine for Childhood Cancer

Learning Objectives: 

 

Discuss the history of treating GD2+ pediatric solid tumors

Examine combination anti-GD2 treatments with NK cells to enhance anti-tumor potency

Describe manufacturing technologies available to genetically engineer immune cells like CRISPR/Cas9

Session date: 
05/14/2026 - 7:30am to 8:30am CDT
Location: 
HSLC 1345 and Virtual via Zoom
United States
See map: Google Maps
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™
Add to calendar: 
Please login or register to take this course.
Discloser List CME Internal Report
Presenter(s): 
Christian Capitini, MD